Most Recent
WiseTech Global faces class action by shareholders
WiseTech has been hit with a class action over disclosures linked to the performance of its acquired businesses, but the recent allegations plaguing the logistics software company could come under the microscope too.
Judge mulls CFO to cut Mayne class action funder’s commission
A commission baked into a funding agreement in a class action against Mayne Pharma is under threat, with a judge mulling an order off his own bat to cut the rate. 
BHP says shareholders can’t expand class action because of ‘drafting error’
BHP has told an appeals court a shareholder class action should not be allowed to expand the group definition to correct an alleged drafting error.
BHP class action gets 3 extra weeks for high-stakes trial
A shareholder class action against BHP over the 2015 Fundao dam collapse in Brazil has won a bid to add an extra three weeks to a six-week hearing to account for any evidentiary surprises.
Medibank says Deloitte data breach report not relevant in shareholder class action
Medibank is seeking to shield from a shareholder class action an "irrelevant" post-incident report by Deloitte into its massive October 2022 data breach.
Funder seeks $10.6M cut from Mayne Pharma class action settlement
The funder and law firm that ran a shareholder class action against Mayne Pharma are seeking deductions that would leave more than half of a $38 million settlement for group members.
Victoria fights protest class action’s bid for police officers’ names
The state of Victoria is resisting a class action’s bid to identify police officers recorded using capsicum spray against protestors at a mining conference in 2019.
Boral class action trial paused as appeal flagged over questioning of ex-CEO
Trial in a shareholder class action against Boral has been halted amid an appeal over a decision to allow questioning of former CEO Michael Kane about an email that mentioned a confidential EY report.
Class action can grill Boral boss over email reference to EY’s dismal take on US biz
Boral's former CEO Michael Kane can be questioned at trial over a reference he made in an email to findings by EY about the building material group's poor performing US windows business, despite claims that the findings were privileged.
Mesoblast reaches settlement in class action over COVID-19 treatment
Mesoblast has agreed to settle a shareholder class action centred on statements to the market about its Remestemcel-L treatment, resolving claims it misrepresented the efficacy of the therapy for COVID-19 patients.